The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection.

The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection.

Identification of the transmitted/founder virus makes possible, for the first time, a genome-wide analysis of host immune responses against the infecting HIV-1 proteome. A complete dissection was made of the primary HIV-1-specific T cell response induced in three acutely infected patients. Cellular...

Descripció completa

Dades bibliogràfiques
Autors principals:	Goonetilleke, N, Liu, M, Salazar-Gonzalez, J, Ferrari, G, Giorgi, E, Ganusov, V, Keele, B, Learn, G, Turnbull, E, Salazar, MG, Weinhold, K, Moore, S, Letvin, N, Haynes, B, Cohen, MS, Hraber, P, Bhattacharya, T, Borrow, P, Perelson, A, Hahn, B, Shaw, G, Korber, B, Mcmichael, A
Format:	Journal article
Idioma:	English
Publicat:	2009

Ítems similars

Quantifying factors determining the rate of CTL escape and reversion during acute and chronic phases of HIV infection
per: Ganusov, V, et al.
Publicat: (2010)

Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection.
per: Ganusov, V, et al.
Publicat: (2011)

The Role of T Cell Immunity in the Control of HIV Infection
per: Goonetilleke, N, et al.
Publicat: (2010)

Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing.
per: Fischer, W, et al.
Publicat: (2010)

OA06-04. The role of early T-cell responses in subjects with acute HIV-1 infection
per: Hahn B, et al.
Publicat: (2009-10-01)

Reversion and T cell escape mutations compensate the fitness loss of a CD8+ T cell escape mutant in their cognate transmitted/founder virus.
per: Song, H, et al.
Publicat: (2014)

Ontogeny of CD8+T Cells in Acute HIV-1 that Inhibit Autologous and Heterologous Transmitted/Founder (T/F) Viruses
per: Freel, SA, et al.
Publicat: (2011)

Resistance of transmitted founder HIV-1 to IFITM-mediated restriction
per: Foster, T, et al.
Publicat: (2016)

Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes
per: Jesus F. Salazar-Gonzalez, et al.
Publicat: (2016-07-01)

Vaccine-elicited systemic and mucosal humoral responses of lactating rhesus monkeys vaccinated with the transmitted/founder HIV Envelope 1086C
per: Fouda G, et al.
Publicat: (2012-09-01)

The immune response during acute HIV-1 infection: clues for vaccine development.
per: Mcmichael, A, et al.
Publicat: (2010)

P20-17. Evolution of multiple transmitted viruses during the early stage of HIV-1 infection
per: McMichael A, et al.
Publicat: (2009-10-01)

T Cell Escape in Subjects with Acute HIV-1 Infection
per: Liu, M, et al.
Publicat: (2008)

The role of early T-cell responses in subjects with acute HIV-1 infection
per: Liu, M, et al.
Publicat: (2009)

Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication.
per: Freel, SA, et al.
Publicat: (2012)

Phenotypic properties of transmitted founder HIV-1.
per: Parrish, N, et al.
Publicat: (2013)

P09-21 LB. Deep sequencing of HIV-1 from acute infection: low initial diversity, and rapid but variable CTL escape
per: Haynes B, et al.
Publicat: (2009-10-01)

HIV-host interactions: implications for vaccine design
per: Haynes, B, et al.
Publicat: (2016)

Sexually transmitted founder HIV-1 viruses are relatively resistant to Langerhans cell-mediated restriction
per: Borrow, P, et al.
Publicat: (2019)

Residual Viremia in Treated HIV+ Individuals.
per: Jessica M Conway, et al.
Publicat: (2016-01-01)

Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection.
per: Ferrari, G, et al.
Publicat: (2011)

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.
per: Borrow, P, et al.
Publicat: (1994)

Sexually transmitted founder HIV-1 viruses are relatively resistant to Langerhans cell-mediated restriction.
per: Nina Hertoghs, et al.
Publicat: (2019-01-01)

Phagocytic uptake of transmitted/founder virus-infected CD4+T cells enhances macrophage infection
per: Duncan, C, et al.
Publicat: (2012)

Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing.
per: Will Fischer, et al.
Publicat: (2010-08-01)

Distinct kinetics of Gag-specific CD4+ and CD8+ T cell responses during acute HIV-1 infection.
per: Riou, C, et al.
Publicat: (2012)

Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4
per: Mark B. Stoddard, et al.
Publicat: (2015-05-01)

Negative and Positive Selection Pressure During Sexual Transmission of Transmitted Founder HIV-1
per: Bernadien M. Nijmeijer, et al.
Publicat: (2019-07-01)

Novel SHIVs encoding transmitted/founder Envs for latency and cure research
per: A. Bauer, et al.
Publicat: (2019-12-01)

A sequestered fusion peptide in the structure of an HIV-1 transmitted founder envelope trimer
per: Neeti Ananthaswamy, et al.
Publicat: (2019-02-01)

Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection
per: Hongshuo Song, et al.
Publicat: (2018-05-01)

High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men.
per: Hui Li, et al.
Publicat: (2010-05-01)

Implications of viral transmitted/founder (T/F) dynamics on vaccine development
per: Alexander I. Mosa
Publicat: (2021-07-01)

Origin and evolution of HIV-1 in breast milk determined by single-genome amplification and sequencing.
per: Salazar-Gonzalez, J, et al.
Publicat: (2011)

A signature in HIV-1 envelope leader peptide associated with transition from acute to chronic infection impacts envelope processing and infectivity.
per: Mohammed Asmal, et al.
Publicat: (2011-01-01)

Postnatally-transmitted HIV-1 variants are efficient at dendritic cell trans-infection and sensitive to autologous and heterologous neutralization
per: Fouda GG, et al.
Publicat: (2012-09-01)

Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7.
per: Nicholas F Parrish, et al.
Publicat: (2012-01-01)

Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants
per: David R. Martinez, et al.
Publicat: (2020-04-01)

P04-41. Kinetics of antibody neutralization and viral evolution following envelope vaccination in SIV-infected rhesus monkeys
per: Korber B, et al.
Publicat: (2009-10-01)

Characterization of Near Full-Length Transmitted/Founder HIV-1 Subtype D and A/D Recombinant Genomes in a Heterosexual Ugandan Population (2006–2011)
per: Sheila N. Balinda, et al.
Publicat: (2022-02-01)